• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form FWP filed by Morgan Stanley

    6/30/25 5:24:38 PM ET
    $MS
    Investment Bankers/Brokers/Service
    Finance
    Get the next $MS alert in real time by email
    FWP 1 ms9175_fwp-19552.htm FREE WRITING PROSPECTUS TO PRELIMINARY PRICING SUPPLEMENT NO. 9,175

    Free Writing Prospectus to Preliminary Pricing Supplement No. 9,175

    Registration Statement Nos. 333-275587; 333-275587-01

    Dated June 30, 2025; Filed pursuant to Rule 433

    Morgan Stanley

    SPX Dual Directional Buffered PLUS due September 8, 2026

    This document provides a summary of the terms of the securities. Investors must carefully review the accompanying preliminary pricing supplement referenced below, product supplement, index supplement and prospectus, and the “Risk Considerations” on the following page, prior to making an investment decision.


    Terms

    Issuer:

    Morgan Stanley Finance LLC

    Guarantor:

    Morgan Stanley

    Underlier:

    S&P 500® Index (SPX)

    Maximum upside payment at maturity:

    $1,113 per security (111.30% of the stated principal amount)

    Leverage factor:

    200%

    Absolute return participation rate:

    100%

    Buffer amount:

    10% (90% maximum loss)1

    Pricing date:

    July 31, 2025

    Observation date:

    September 2, 2026

    Maturity date:

    September 8, 2026

    CUSIP:

    61778NFR7

    Estimated value:

    $989.70 per security, or within $35.00 of that estimate

    Preliminary pricing supplement:

    https://www.sec.gov/Archives/edgar/data/895421/000183988225035833/ms9175_424b2-19551.htm

    1All payments are subject to our credit risk

     

    Hypothetical Payment at Maturity1

    The payoff diagram and table below illustrate the payment at maturity for a range of hypothetical performances of the underlier over the term of the securities.

    % Change in Closing Level of the Underlier

    Payment at Maturity per Security

    +60.00%

    $1,113.00

    +40.00%

    $1,113.00

    +20.00%

    $1,113.00

    +10.00%

    $1,113.00

    +5.65%

    $1,113.00

    +5.00%

    $1,100.00

    0.00%

    $1,000.00

    -5.00%

    $1,050.00

    -10.00%

    $1,100.00

    -11.00%

    $990.00

    -20.00%

    $900.00

    -40.00%

    $700.00

    -60.00%

    $500.00

    -80.00%

    $300.00

    -100.00%

    $100.00


     

     

    The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling toll-free 1-800-584-6837.

    Underlier(s)

    For more information about the underlier(s), including historical performance information, see the accompanying preliminary pricing supplement.

    Risk Considerations

    The risks set forth below are discussed in more detail in the “Risk Factors” section in the accompanying preliminary pricing supplement. Please review those risk factors carefully prior to making an investment decision.

    Risks Relating to an Investment in the Securities

    ●The securities provide for only the minimum payment at maturity and do not pay interest.

    ●The appreciation potential of the securities is limited by the maximum upside payment at maturity.

    ●Any positive return on the securities that is based on the depreciation of the underlier is effectively capped.

    ●The amount payable on the securities is not linked to the value of the underlier at any time other than the observation date.

    ●The market price of the securities may be influenced by many unpredictable factors.

    ●The securities are subject to our credit risk, and any actual or anticipated changes to our credit ratings or credit spreads may adversely affect the market value of the securities.

    ●As a finance subsidiary, MSFL has no independent operations and will have no independent assets.

    ●The rate we are willing to pay for securities of this type, maturity and issuance size is likely to be lower than the rate implied by our secondary market credit spreads and advantageous to us. Both the lower rate and the inclusion of costs associated with issuing, selling, structuring and hedging the securities in the original issue price reduce the economic terms of the securities, cause the estimated value of the securities to be less than the original issue price and will adversely affect secondary market prices.

    ●The estimated value of the securities is determined by reference to our pricing and valuation models, which may differ from those of other dealers and is not a maximum or minimum secondary market price.

    ●The securities will not be listed on any securities exchange and secondary trading may be limited.

    ●As discussed in more detail in the accompanying product supplement, investing in the securities is not equivalent to investing in the underlier(s).

    ●The U.S. federal income tax consequences of an investment in the securities are uncertain.

    Risks Relating to the Underlier(s)

    ●Because your return on the securities will depend upon the performance of the underlier(s), the securities are subject to the following risk(s), as discussed in more detail in the accompanying product supplement.

    oAdjustments to an underlying index could adversely affect the value of the securities.

    Risks Relating to Conflicts of Interest

    ●The calculation agent, which is a subsidiary of Morgan Stanley and an affiliate of MSFL, will make determinations with respect to the securities.

    ●Hedging and trading activity by our affiliates could potentially adversely affect the value of the securities.

    Tax Considerations

    You should review carefully the discussion in the accompanying preliminary pricing supplement under the caption “Additional Information About the Securities– United States federal income tax considerations” concerning the U.S. federal income tax consequences of an investment in the securities, and you should consult your tax adviser.

     

    Get the next $MS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MS

    DatePrice TargetRatingAnalyst
    11/26/2024Buy → Hold
    HSBC Securities
    11/15/2024$142.00Underweight → Equal Weight
    Wells Fargo
    10/4/2024$118.00Hold → Buy
    HSBC Securities
    9/11/2024Buy → Neutral
    Goldman
    8/2/2024$99.00 → $95.00Equal Weight → Underweight
    Wells Fargo
    7/17/2024Outperform → Perform
    Oppenheimer
    1/17/2024$94.00 → $87.00Overweight → Neutral
    JP Morgan
    1/17/2024$102.00 → $91.00Outperform → Mkt Perform
    Keefe Bruyette
    More analyst ratings

    $MS
    SEC Filings

    See more
    • SEC Form FWP filed by Morgan Stanley

      FWP - MORGAN STANLEY (0000895421) (Subject)

      7/1/25 9:11:13 AM ET
      $MS
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form FWP filed by Morgan Stanley

      FWP - MORGAN STANLEY (0000895421) (Subject)

      7/1/25 9:09:50 AM ET
      $MS
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form FWP filed by Morgan Stanley

      FWP - MORGAN STANLEY (0000895421) (Subject)

      7/1/25 9:08:05 AM ET
      $MS
      Investment Bankers/Brokers/Service
      Finance

    $MS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Leibowitz Shelley B was granted 2,155 shares, increasing direct ownership by 5% to 48,614 units (SEC Form 4)

      4 - MORGAN STANLEY (0000895421) (Issuer)

      6/3/25 4:09:40 PM ET
      $MS
      Investment Bankers/Brokers/Service
      Finance
    • Director Nally Dennis M was granted 2,155 shares, increasing direct ownership by 5% to 44,385 units (SEC Form 4)

      4 - MORGAN STANLEY (0000895421) (Issuer)

      6/3/25 4:09:28 PM ET
      $MS
      Investment Bankers/Brokers/Service
      Finance
    • Director Butler Megan was granted 2,155 shares and covered exercise/tax liability with 286 shares, increasing direct ownership by 68% to 4,624 units (SEC Form 4)

      4 - MORGAN STANLEY (0000895421) (Issuer)

      6/3/25 4:09:15 PM ET
      $MS
      Investment Bankers/Brokers/Service
      Finance